Dechert LLP

10/22/2021 | Press release | Distributed by Public on 10/22/2021 13:45

Dechert Shepherds Tiziana on Novel Path to Value Creation with Completion of Migration and Common Share Nasdaq Listing

Dechert has advised Tiziana Life Sciences on its jurisdictional migration and movement from listings on both the Main Market of the London Stock Exchange and NASDAQ to a sole listing on NASDAQ. A new Bermuda incorporated company was established as the ultimate parent company of the Tiziana group and the reorganisation was effected by an English-law scheme of arrangement. Tiziana eliminated its ADR program and established a direct listing of common shares on NASDAQ as a consequence of the transaction.

Tiziana Life Sciences is a biotechnology company that focuses on the discovery and development of novel molecules to treat human diseases in oncology, inflammation and infectious diseases.

The cross-border Dechert team that advised Tiziana includes corporate partners David Rosenthal, Sean Geraghty and Gregory Schernecke, and associates Jodie Valler-Feltham, Rose Limaye and Marie Mast, and tax partners Daniel Hawthorne and Mark Stapleton, and associate Nicolas Kokkinos.

About Dechert

Dechert is a leading global law firm with 22 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.